Navigating Compassionate Use in Clinical Research: Unpacking FDA’s Latest Guidance
Compassionate use, also known as expanded access, is a critical pathway for patients with life-threatening conditions to access investigational...
Moe Alsumidaie
How to Harness Data Science to Predict Clinical Trial Outcomes
In today’s world, where data drives many decisions, the biopharmaceutical industry is no exception. Integrating data science into clinical...
Are Clinical Research Sites Just Whiners or Genuine Victims?
In recent times, LinkedIn has transformed from a platform for professional networking to a sounding board for industry grievances....
CTMS BOT: A New Tool for Clinical Trial Automation
In the realm of clinical studies, the nuances and enormous datasets necessitate utmost precision, swift actions, and efficiency. Astellas,...
Patient Engagement Scores: How Do Different Therapeutic Areas Compare?
The value of patient-centric approaches has never been more evident in clinical trials. The FDA encourages patient engagement in...
How MERIS Total Engagement Solution is Ushering in a New Era of Transparency in Patient Recruitment
In the rapidly evolving landscape of clinical trial patient recruitment, the challenges of patient recruitment, patient retention, and data...
Pharma R&D and GxP Quality Assurance Can Be Improved by AI
The rapidly evolving field of artificial intelligence (AI) and data analytics offers immense potential for enhancing clinical trial quality...
How to Make Clinical Trials for Elderly with Disabilities More Inclusive
The global demographic is undergoing a significant shift, with an increasing number of elderly patients. This aging population brings...
How to Bolster Clinical Operations in the Post-COVID-19 Pandemic World
Clinical Operations, the backbone of the clinical trials sector, has been impacted by the COVID-19 pandemic. Post-pandemic, many clinical...